Skip to main content
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
101.21
+2.70 (2.74%)
At close: Apr 28, 2026, 4:00 PM EDT
102.49
+1.28 (1.26%)
Pre-market: Apr 29, 2026, 5:36 AM EDT

Protagonist Therapeutics Revenue

In the year 2025, Protagonist Therapeutics had annual revenue of $46.02M, down -89.41%. Protagonist Therapeutics had revenue of $7.44M in the quarter ending December 31, 2025, a decrease of -95.64%.

Revenue (ttm)
$46.02M
Revenue Growth
-89.41%
P/S Ratio
140.34
Revenue / Employee
$348,606
Employees
132
Market Cap
6.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202546.02M-388.42M-89.41%
Dec 31, 2024434.43M374.43M624.06%
Dec 31, 202360.00M33.42M125.73%
Dec 31, 202226.58M-776.00K-2.84%
Dec 31, 202127.36M-1.27M-4.44%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

PTGX News

More News